Quinapril Tablet
NDC Package 69097-839-05

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Quinapril tablets is classified as a

administered via oral route. This formulation utilizes a tablet delivery system. Marketed by Cipla Usa Inc., this product is identified by NDC 69097-839 and is authorized under FDA application ANDA078457.

Identification & Billing

NDC Package Code
69097-839-05
Package Description
90 TABLET in 1 BOTTLE
Product Code
69097-839
11-Digit Billing Format
69097083905
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Quinapril
Non-Proprietary Name
Quinapril
Substance Name
Quinapril Hydrochloride
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
QUINAPRIL HYDROCHLORIDE 5 mg/1
Pharmacologic Class

Regulatory & Marketing

Labeler Name
Cipla Usa Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA078457
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
07-22-2016
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (69097-839). Click a package code to view its specific billing and regulatory data.

69097-839-15
1000 TABLET in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69097-839-05 identifies a specific commercial package of 90 tablet in 1 bottle of Quinapril, a human prescription drug labeled by Cipla Usa Inc.. This tablet is formulated for oral use and contains quinapril hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cipla Usa Inc. on July 22, 2016. The current certification is valid through December 31, 2026.

How is this Cipla Usa Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69097083905. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69097-839-05
11-Digit CMS (5-4-2)
69097-0839-05

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.